|
ZNF416 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.62090000000293E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.576390E-04 |
| Normal-vs-Stage2 |
8.959200E-03 |
| Normal-vs-Stage3 |
3.69829999999904E-05 |
| Normal-vs-Stage4 |
5.51530000003631E-07 |
| Stage1-vs-Stage2 |
3.799200E-01 |
| Stage1-vs-Stage3 |
1.918030E-01 |
| Stage1-vs-Stage4 |
1.446410E-02 |
| Stage2-vs-Stage3 |
1.302810E-01 |
| Stage2-vs-Stage4 |
1.156390E-02 |
| Stage3-vs-Stage4 |
1.961600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.59259999999684E-05 |
| Normal-vs-AfricanAmerican |
2.407600E-02 |
| Normal-vs-Asian |
1.279960E-03 |
| Caucasian-vs-AfricanAmerican |
6.485800E-01 |
| Caucasian-vs-Asian |
7.171200E-01 |
| AfricanAmerican-vs-Asian |
8.678000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.822200E-04 |
| Normal-vs-Female |
3.61730000000282E-05 |
| Male-vs-Female |
2.627800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.23039999999575E-05 |
| Normal-vs-Age(41-60Yrs) |
2.020800E-04 |
| Normal-vs-Age(61-80Yrs) |
3.9083999999967E-05 |
| Normal-vs-Age(81-100Yrs) |
4.634600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.289200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.306200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.852400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.602600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.515200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.118600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.560400E-02 |
| Classical-VS-Follicular |
5.696700E-03 |
| Classical-VS-Other |
6.818200E-01 |
| Classical-VS-Normal |
7.583600E-04 |
| Tall-VS-Follicular |
8.781800E-01 |
| Tall-VS-Other |
6.989400E-01 |
| Tall-VS-Normal |
2.01859999999776E-05 |
| Follicular-VS-Other |
6.503400E-01 |
| Follicular-VS-Normal |
1.52727999999103E-05 |
| Other-VS-Normal |
1.141190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.350900E-04 |
| Normal-vs-N1 |
1.22280000014463E-07 |
| N0-vs-N1 |
1.058660E-03 |
|
|
